Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > Willow Shareholders Future

<< Previous

Bullboard Posts

Next >>

Post by jermiah777on Jul 08, 2021 4:27pm

318 Views

Post# 33516176

Willow Shareholders Future

Well...the current share price is concerning to retail shareholders. What about management? Are they concerned? I checked at "Canadian insider.com" and noticed Lalani Sadiq , a director just purchased another 30000 ( thirty thousand) shares from the common market at 1.02 and 1.01 So that is encouraging. Clearly he feels this is a great buying opportunity. He already owns a very substantial amount. So to add to it is encouraging.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec